MAXIM PHARMACEUTICALS REPORTS FISCAL 2005 FINANCIAL RESULTS

Maxim Pharmaceuticals, Inc. today reported financial results for the fourth quarter and the year ended September 30, 2005. The net loss applicable to common stock for the fourth quarter ended September 30, 2005 totaled $5.9 million, or $0.21 per share, compared to a net loss applicable to common stock of $14.5 million, or $0.51 per share, for the same period of the prior year.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051214005171&newsLang=en)